FDA says yes to the tests
AI software capable of mapping tumor tissue more accurately to help surgeons treat and shrink prostate cancer using a laser-powered needle will soon be tested in real patients during clinical trials.
Treatment for prostate cancer varies depending on the severity of the disease. Patients can undergo hormone therapy, chemotherapy, or surgery to remove tissue. Avenda Health, a medical startup founded in 2017, is developing a new type of treatment that is less invasive. The US Food and Drug Administration granted an investigational device exemption to the company's invention this week, meaning it can now be used in a clinical study.
MRI images where cancer is mapped using iQuest software before and after treatment. Image Credit: Avenda Health
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Experts urge FDA to include T cell responses when evaluating COVID vaccinesNow, a group of prominent scientists and physicians are urging the FDA to include in its guidance to vaccine developers a recommendation for T-cell assessment in COVID-19 vaccine clinical trials to more comprehensively measure immune response.
Read more »
'The earlier it’s caught the easier it is to treat!' Men urged to take advantage of free cancer testMen are being urged to go along to get a free prostate cancer check in Wellington next month.
Read more »
Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic TestingThis cohort study assesses the diagnostic yield and clinical management implications of combined cardiomyopathy and arrhythmia genetic testing among patients with a suspected genetic cardiomyopathy or arrhythmia.
Read more »
You can now sell your DALL-E 2 art, but it feels murkyYou can now sell your DALL-E 2 art, but it feels murky.
Read more »
Aldi issues message to customers on changes to its milkIt could be rolled out nationwide
Read more »